Researchers Behind mRNA Technology for COVID Vaccines Win Nobel Prize in Medicine
The Nobel Prize in Medicine has been awarded to American scientists Victor Ambros and Gary Ruvkun for their groundbreaking discovery of microRNA, a key element in the regulation of gene activity.
Their work, conducted at prestigious institutions such as Harvard University and Massachusetts General Hospital, has greatly advanced the understanding of how organisms develop and function.
The Nobel Assembly emphasized that this discovery is “proving to be fundamentally important” in the field of biology.
Ambros made his landmark discovery at Harvard and is currently a professor of natural science at the University of Massachusetts Medical School. Ruvkun carried out his research at Massachusetts General Hospital and Harvard Medical School, where he now serves as a genetics professor, according to Thomas Perlmann, Secretary-General of the Nobel Committee.
Last year, the Nobel Prize in Physiology or Medicine was awarded to Katalin Karikó, a Hungarian-American, and American Drew Weissman for their contributions to the development of mRNA vaccines, which played a crucial role in combating the COVID-19 pandemic. The prize comes with a cash award of 11 million Swedish kronor (around $1 million), funded by the legacy of Swedish inventor Alfred Nobel.
This announcement kicks off this year’s Nobel Prize season, with physics to follow on Tuesday, chemistry on Wednesday, and literature on Thursday. The Nobel Peace Prize will be revealed on Friday, and the Nobel Memorial Prize in Economic Sciences on October 14.
The laureates will receive their awards during ceremonies on December 10, the anniversary of Alfred Nobel’s passing.
Follow us on our social media platforms here: Twitter WHATSAPP CHANNEL FACEBOOK PAGE
Comments are closed, but trackbacks and pingbacks are open.